MICHAEL LAWRENCE DOUGAN

Allopathic & Osteopathic Physicians|Internal Medicine|Gastroenterology BOSTON, MA NPI 1225322258

General Payments — all program years on this page

$32,122.44

  • Category: General Payments
  • Program years: PY2018–2024
  • Record count: 32
  • As of (CMS publication): 2026-01-23

Latest program year (PY2024): $14,933.94 across 14 records · disputed records: 0

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How this figure is calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

Latest program year (PY2024) · sorted by reported total.

By paying entity

Latest program year (PY2024) · sorted by reported total.

Paying entityAmountRecords
Regeneron Pharmaceuticals, Inc. $9,858.6910
Mallinckrodt Hospital Products Inc. $4,710.003
Partner Therapeutics, Inc. $365.251

By program year

Program yearAmountRecords
2018 $3,598.416
2019 $2,100.002
2020 $1,325.002
2021 $5,635.004
2022 $4,137.593
2023 $392.501
2024 $14,933.9414

Records — PY2024 (14)

Record IDPaying entityAmountDate Nature of paymentDispute statusPublishedSource
1114398423 Regeneron Pharmaceuticals, Inc. $35.25 06/28/2024 Travel and Lodging Undisputed 01/23/2026 View at CMS
1114398425 Regeneron Pharmaceuticals, Inc. $261.48 06/28/2024 Travel and Lodging Undisputed 01/23/2026 View at CMS
1114398427 Regeneron Pharmaceuticals, Inc. $223.75 07/11/2024 Travel and Lodging Undisputed 01/23/2026 View at CMS
1114398429 Regeneron Pharmaceuticals, Inc. $134.32 07/11/2024 Travel and Lodging Undisputed 01/23/2026 View at CMS
1114398431 Regeneron Pharmaceuticals, Inc. $64.41 07/26/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1114398433 Regeneron Pharmaceuticals, Inc. $112.79 07/26/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1114398435 Regeneron Pharmaceuticals, Inc. $17.69 07/26/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1114398437 Regeneron Pharmaceuticals, Inc. $1,287.00 09/06/2024 Consulting Fee Undisputed 01/23/2026 View at CMS
1114398439 Regeneron Pharmaceuticals, Inc. $4,290.00 09/06/2024 Consulting Fee Undisputed 01/23/2026 View at CMS
1114398441 Regeneron Pharmaceuticals, Inc. $3,432.00 09/06/2024 Consulting Fee Undisputed 01/23/2026 View at CMS
1141329054 Partner Therapeutics, Inc. $365.25 01/15/2024 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Undisputed 01/23/2026 View at CMS
1145066401 Mallinckrodt Hospital Products Inc. $785.00 03/07/2024 Consulting Fee Undisputed 01/23/2026 View at CMS
1145066405 Mallinckrodt Hospital Products Inc. $785.00 03/07/2024 Consulting Fee Undisputed 01/23/2026 View at CMS
1145066409 Mallinckrodt Hospital Products Inc. $3,140.00 03/07/2024 Consulting Fee Undisputed 01/23/2026 View at CMS

Provenance & corrections

  • Dataset: CMS Open Payments — General Payments
  • Source: CMS Open Payments dataset (bulk file)
  • Publisher of source data: Centers for Medicare & Medicaid Services
  • Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.